# Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED

> **NCT02390960** · PHASE2 · COMPLETED · sponsor: **Strategic Science & Technologies, LLC** · enrollment: 33 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Sildenafil Cream
- **DRUG:** Placebo Cream
- **DEVICE:** Penile Plethysmography (RigiScan)

## Key facts

- **NCT ID:** NCT02390960
- **Lead sponsor:** Strategic Science & Technologies, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2017-04
- **Final completion:** 2017-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02390960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02390960, "Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02390960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*